NY-ESO-1 as a potential immunotherapeutic target in renal cell carcinoma
Background: Novel immune therapies targeting tumor specific antigens are being developed. Our purpose was to determine expression of the cancer testes antigen NY-ESO-1 in renal cell carcinoma (RCC), as NY-ESO-1 targeting approaches, particularly adoptive cell therapy, have not been evaluated in this...
Full description
Bibliographic Details
| Main Authors: |
Giesen, Eva,
Jilaveanu, Lucia B.,
Parisi, Fabio,
Kluger, Yuval,
Camp, Robert L.,
Kluger, Harriet M. |
|---|
| Format: | Online
|
|---|
| Language: | English |
|---|
| Published: |
Impact Journals LLC
2014
|
|---|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170640/
|
|---|